Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Lipids ; 43(3): 243-9, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18256867

RESUMO

Lysophosphatidylcholine (LysoPtdCho) levels are elevated in sera in patients with atherosclerosis and in atherosclerotic tissue. Previous studies have shown that reactive chlorinating species attack plasmalogens in human coronary artery endothelial cells (HCAEC), forming lysoPtdCho and lysoPtdCho-chlorohydrin (lysoPtdCho-ClOH). The results herein demonstrate for the first time that lysoPtdCho-ClOH is elevated over 60-fold in human atherosclerotic lesions. In cultured HCAEC, 18:0 lysoPtdCho-ClOH led to a statistically significant increase in P-selectin cell-surface expression, but unlike 18:1 lysoPtdCho did not lead to cyclooxygenase-2 protein expression. These data show that 18:0 lysoPtdCho-ClOH is elevated in atherosclerotic tissue and may have unique pro-atherogenic properties compared to lysoPtdCho.


Assuntos
Aterosclerose/metabolismo , Cloridrinas/análise , Vasos Coronários/metabolismo , Endotélio Vascular/metabolismo , Lisofosfatidilcolinas/análise , Selectina-P/metabolismo , Aorta/química , Células Cultivadas , Cloridrinas/sangue , Cloridrinas/farmacologia , Ciclo-Oxigenase 2/metabolismo , Células Endoteliais/metabolismo , Humanos , Lisofosfatidilcolinas/sangue , Lisofosfatidilcolinas/farmacologia , Espectrometria de Massas por Ionização por Electrospray
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA